Experimental Studies of the Effects of the Dopamine D2 Receptor Agonist Cabergoline on Catecholamine Content and BDNF mRNA Expression in the Midbrain and Hypothalamus
Crossref DOI link: https://doi.org/10.1007/s11055-020-00974-3
Published Online: 2020-10-07
Published Print: 2020-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Anokhin, P. K.
Veretinskaya, A. G.
Pavshintsev, V. V.
Shamakina, I. Yu.
Text and Data Mining valid from 2020-09-01
Version of Record valid from 2020-09-01
Article History
Received: 21 May 2019
Accepted: 31 July 2019
First Online: 7 October 2020